-
-
-
Nippon Paints's Q1 2025 Financial report
Market Trend
Nippon Paint reports 2.6834 Billion dollars Q1 revenue in FY2025, with China retail up 5% and net profit rising 13%. Despite a slight dip in China revenue, profits surged due to cost controls and volume growth.
-
Asian Paints's Q1 2025 Financial report
Market Trend
Discover the fascinating story behind the discovery of #streptomycin and its impact on #tuberculosis treatment. Explore the clash between mentor and student, #Waksman and #Schatz, and the legacy of this groundbreaking antibiotic.
-
-
Takeda Shuts Down EGFR, B7-H3 Programs
Takeda
Takeda announces major R&D cuts, discontinuing EGFR and B7-H3 oncology projects from its $525M Maverick deal, and streamlining other pipelines to focus on high-potential therapies.
-
Takeda's 2024 Q4 Financial report
Market Trend
Takeda's 2024 fiscal report shows 7.4% revenue growth to ¥4.58T, driven by strong core business and R&D breakthroughs. Key segments include GI, rare diseases, oncology. Outlook for 2025 remains stable despite VYVANSE competition.
-
Axalta's Q1 2025 Financial report
Market Trend
Axalta reported Q1 2025 revenue of $1.262 billion, down 2.5% YoY, with strong 17% growth in China driven by surging auto production. Net income rose 154% to $99M amid cost improvements.
-
BeiGene's Q1 2025 Financial report
Market Trend
BeiGene's Q1 2025 report highlights a 50.2% revenue growth, with zanubrutinib sales exceeding 5 billion RMB and achieving its first quarterly profit under US GAAP. The company also advances its oncology pipeline globally.
-
雅安市|
东乌|
桃源县|
滕州市|
云林县|
治县。|
秀山|
广州市|
保定市|
谷城县|
马边|
武平县|
仁寿县|
赤城县|
开封县|
佛坪县|
侯马市|
株洲县|
越西县|
沙河市|
徐州市|
始兴县|
绥江县|
成安县|
北票市|
巢湖市|
安阳县|
临西县|
梁山县|
长子县|
诏安县|
开封县|
尤溪县|
永泰县|
铁岭县|
东乡族自治县|
馆陶县|
亳州市|
玉门市|
房山区|
乌鲁木齐市|